Cidara Therapeutics, Inc. is an innovative biotechnology company based in San Diego, California, specializing in the discovery and development of novel long-acting anti-infective therapies aimed at addressing significant unmet medical needs in infectious diseases. By leveraging its proprietary Cloudbreak™ platform, Cidara is pioneering the creation of targeted treatment options that enhance patient outcomes and improve compliance. The company’s robust pipeline includes potential therapeutics for both fungal and bacterial infections, positioning it strategically within the evolving landscape of infectious disease management.